Showing 361 - 380 results of 1,388 for search '"immunosuppression"', query time: 0.06s Refine Results
  1. 361

    A Rare Occurrence of Primary Hepatic Leiomyosarcoma Associated with Epstein Barr Virus Infection in an AIDs Patient by Haritha Chelimilla, Kanthi Badipatla, Ariyo Ihimoyan, Masooma Niazi

    Published 2013-01-01
    “…Close association of Epstein Barr virus (EBV) induced soft tissue sarcomas is proven, especially in the presence of immunosuppression encountered in HIV/AIDS patients and in posttransplant patients. …”
    Get full text
    Article
  2. 362

    NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance by Shaoyan Shi, Xuehai Ou, Chao Liu, Rui Li, Qianjin Zheng, Leiming Hu

    Published 2025-01-01
    “…This research aimed to explore how NF-κB influences the recruitment and polarization of tumor-associated macrophages and myeloid-derived suppressor cells, both of which contribute to immunosuppression. Furthermore, NF-κB facilitates immune surveillance evasion in osteosarcoma cells by altering the expression of immune checkpoint molecules, such as PD-L1. …”
    Get full text
    Article
  3. 363

    Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura by Zakaria Hindi, Nirmal Onteddu, Christopher A. Ching, Abdallah A. Khaled

    Published 2017-01-01
    “…While usage of antiplatelet therapy in such patients is debated, immunosuppression therapy has been the mainstay treatment in all published cases.…”
    Get full text
    Article
  4. 364

    Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two by Azhar Kareem Razzaq, Ameer Al-Jasim

    Published 2021-01-01
    “…ITP is treated with immunosuppression. Case Presentation. A 26-year-old Iraqi male laboratory analyst with an unremarkable medical history presented with severe thrombocytopenia 2 days after receiving the Oxford-AstraZeneca coronavirus disease-2019 vaccine. …”
    Get full text
    Article
  5. 365

    ACSL4 promotes the formation of the proliferative subtype in hepatoblastoma by Wei Dang, Qin Li, Xiaoying Wang

    Published 2025-02-01
    “…Among them, the proliferative subtype, characterized by enhanced proliferative capacity, poor prognosis, and an immunosuppressive tumor microenvironment, was particularly notable. …”
    Get full text
    Article
  6. 366

    Pancreatitis in systemic lupus erythematosus: Clinical characterization and outcome analysis in concurrent pancreatitis and lupus by Sheba Charles, Benzeeta Pinto, Vineeta Shobha

    Published 2021-01-01
    “…All our patients were treated with high-dose steroids and other immunosuppression as indicated for concomitant disease activity. …”
    Get full text
    Article
  7. 367

    Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis by Wassim Elyaman, Samia J. Khoury, David W. Scott, Anne S. De Groot

    Published 2011-01-01
    “…Tregitopes expand Treg cells and induce “adaptive Tregs” resulting in immunosuppression and, therefore, are being considered as a potential therapy for autoimmune diseases. …”
    Get full text
    Article
  8. 368

    Ocular manifestations of COVID-19 by Sandra Saray Quignón Santana, Osbel Alfonso Sánchez, Sandra Alfonso Quignón, Talía Alfonso Quignón

    Published 2022-12-01
    “…In the recovery stage, ocular findings associated with systemic immunosuppression, vasculitic and thromboembolic processes are presented. …”
    Get full text
    Article
  9. 369

    Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis by L. Stratton, G. R. Caddy

    Published 2016-01-01
    “…Patients with Crohn’s disease often require the use of immunosuppressant drugs to control disease activity. Such medication includes steroids, azathioprine, and biologic therapy. …”
    Get full text
    Article
  10. 370

    Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement by Stephan Zaenker, Stefan Schweyer, Justin Hasenkamp, Lorenz Truemper, Gerald Wulf

    Published 2011-01-01
    “…The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. …”
    Get full text
    Article
  11. 371

    Vascular cytoprotection, autoimmune disease, and premature atherosclerosis by Justin C Mason

    Published 2018-01-01
    “…Identification of safe therapeutic approaches that combine the targeted immunosuppression required, along with comprehensive vascular protection to control the primary disease and prevent secondary complications over the longer term, remains the ultimate challenge.…”
    Get full text
    Article
  12. 372

    Disseminated Necrotizing Leukoencephalopathy Complicating Septic Shock in an Immunocompetent Patient by Pedro Gaspar-da-Costa, Sofia Reimão, Sandra Braz, João Meneses Santos, Rui M. M. Victorino

    Published 2017-01-01
    “…DNL was initially thought to be exclusively associated with immunosuppression conditions but it has been recently described in immunocompetent patients in septic shock. …”
    Get full text
    Article
  13. 373

    An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome by Angela J. Westover, Kimberly A. Johnston, Deborah A. Buffington, H. David Humes

    Published 2016-01-01
    “…Specific approaches targeting monocytes/ATM may improve insulin resistance without the adverse side effects of generalized immunosuppression. In this regard, a biomimetic membrane leukocyte processing device, called the selective cytopheretic device (SCD), was evaluated in an Ossabaw miniature swine model of insulin resistance with metabolic syndrome. …”
    Get full text
    Article
  14. 374

    IAPSM’s Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India by Chythra R. Rao, Veena G. Kamath, Anuradha Nadda, Swayam P. Parida, Nikita Sharma, Kapil Goel, Ranjitha S. Shetty, Madhur Verma, Arvind Kumar Singh, Abhisek Mishra, Swosti Kiran, Lalit Sankhe, Madhu Gupta

    Published 2024-12-01
    “…Pneumococcal vaccination is suggested for people aged 19–64 years with immunosuppression, chronic cardiac, lung and hepatic disease, impaired splenic function, uncontrolled diabetes mellitus, current smokers, and those abusing alcohol. …”
    Get full text
    Article
  15. 375

    Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis by Abigayle Sullivan, Theresa Lanham, Ronald Krol, Shilla Zachariah

    Published 2020-01-01
    “…This case is a rare example of PCP in a patient with a normal CD4 count (>487 cells/μL) and a low viral load (<20 copies/mL) despite PCP prophylactic antibiotics in the setting of recent iatrogenic immunosuppression.…”
    Get full text
    Article
  16. 376

    A Rare Case of Suppurative Aspergillosis of the Thyroid by Nikhil Dinaker Thada, Sampath Chandra Prasad, Bhasker Alva, Monika Pokharel, Kishore Chandra Prasad

    Published 2013-01-01
    “…Fungal infections of the thyroid usually occur in immunocompromised patients with hematological malignancies, recipients of bone marrow and solid organ allografts on immunosuppression, and patients with AIDS. A 65-year-old male presented with swelling in the front of the neck for 2 years. …”
    Get full text
    Article
  17. 377

    Clostridium septicum Gas Gangrene in Colon Cancer: Importance of Early Diagnosis by Sowmya Nanjappa, Sweta Shah, Smitha Pabbathi

    Published 2015-01-01
    “…Clostridium septicum is a rare subgroup known to cause atraumatic myonecrosis and is associated with colonic malignancy or immunosuppression. It is a Gram-positive, anaerobic, spore-forming bacillus found in the gastrointestinal tract and can lead to direct, spontaneous infections of the bowel and peritoneal cavity. …”
    Get full text
    Article
  18. 378

    Binary and quaternary mixtures of perfluoroalkyl substances (PFAS) differentially affect the immune response to influenza A virus infection by Christina M. Post, Carrie McDonough, B. Paige Lawrence

    Published 2024-12-01
    “…PFAS often co-occur as mixtures in the environment, however, few studies have examined immunosuppression of PFAS mixtures or determined whether PFAS exposure affects immune function in the context of infection. …”
    Get full text
    Article
  19. 379

    Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas by Ozden Oz, Asuman Argon, Tulu Ayata Kebat, Ozlem Ozdemir, Savas Yakan

    Published 2023-07-01
    “…Tyrosine kinase receptors (TKRs) are responsible for cell plasticity, chemoresistance, immunosuppression and metastasis potential. Axl is a receptor of the TKR family, and it has come to the fore in cancer treatment in the last decade. …”
    Get full text
    Article
  20. 380

    Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis by Irfan Moinuddin, Bijin Thajudeen, Amy Sussman, Machaiah Madhrira, Erika Bracamonte, Mordecai Popovtzer, Pradeep V. Kadambi

    Published 2016-01-01
    “…However, we chose not to augment immunosuppression. The patient’s kidney allograft function improved over time with close monitoring. …”
    Get full text
    Article